More on Christopher & Banks' Q3

|About: Christopher & Banks Cor... (CBK)|By:, SA News Editor

Christopher & Banks (NYSE:CBK) reports comparable sales rose 4.5% in Q3.

Gross margin rate expanded 95 bps to 36.8%.

SG&A expense rate improved 190 bps to 30.5%.

Adjusted EBITDA +75.7% to $6.74M.

Q4 Guidance: Net sales: $93M to $97M; Comparable sales: +1% to +5%; Adjusted EBITDA: -$0.6M to -$2.4M; D&A: ~$3.4M; Net loss: $4.1M to $5.9M; Diluted EPS: -$0.11 to -$0.16; Average square footage: -5% Y/Y.

FY2016 Guidance: Capex: ~$12.5M to $12.5M; Average square footage: ~-1.6% Y/Y.

Subscribe for full text news in your inbox